Validations: Documentation & Trending

CAPA Effectiveness: Close the Loop with Trending

CAPA Effectiveness: Close the Loop with Trending In the regulated pharmaceutical environment, ensuring compliance with standards set forth by authorities such as the FDA, EMA, and MHRA is essential for maintaining product quality and safety. One crucial aspect of this compliance is the Control of Nonconformance and Corrective and Preventive Actions (CAPA) processes. Particularly, effective CAPA systems are necessary for…

Continue Reading CAPA Effectiveness: Close the Loop with Trending

Risk Review Cadence for Hold-Time Claims

Risk Review Cadence for Hold-Time Claims Introduction to Hold-Time Studies In the pharmaceutical industry, adhering to stringent regulatory requirements regarding equipment and material holds is critical for ensuring product safety, quality, and efficacy. Hold-time studies, particularly focusing on bulk and intermediate products, are essential for establishing the maximum permissible time before products are subject to microbial or endotoxin contamination. This…

Continue Reading Risk Review Cadence for Hold-Time Claims

Training and Re-Training Based on Trends

Training and Re-Training Based on Trends In the pharmaceutical industry, robust documentation practices are essential for maintaining compliance and ensuring product safety. This article provides a comprehensive guide on conducting hold-time studies, focusing on equipment hold time, bulk hold time, and intermediate hold time. It also emphasizes the importance of trending data to support ongoing training and re-training efforts. Understanding…

Continue Reading Training and Re-Training Based on Trends

Governance for Hold-Time Across Networks

Governance for Hold-Time Across Networks The regulatory landscape of the pharmaceutical industry necessitates stringent adherence to guidelines regarding hold times of equipment and materials, especially regarding bulk and intermediate products. This tutorial aims to guide professionals in governance surrounding equipment hold time and its implications on documentation, specifically in relation to microbial limits and endotoxin testing. Understanding Hold Times in…

Continue Reading Governance for Hold-Time Across Networks

Common Trending Pitfalls—and Fixes

Common Trending Pitfalls—and Fixes Common Trending Pitfalls—and Fixes In the pharmaceutical industry, adhering to proper validation processes is vital to ensure compliance with FDA, EMA, MHRA, and PIC/S guidelines. One crucial aspect of this compliance is the management of hold times for both bulk and intermediate products, as well as cleaning processes. This article provides a detailed step-by-step tutorial that…

Continue Reading Common Trending Pitfalls—and Fixes

Peer Review Checklists for Hold Documentation

Peer Review Checklists for Hold Documentation Peer Review Checklists for Hold Documentation Introduction to Hold Documentation in Pharmaceutical Validation Hold documentation is a critical aspect of pharmaceutical validation, particularly relevant in the context of equipment hold time studies, bulk hold time, and intermediate hold time. Properly managed documentation ensures that products remain compliant with regulatory standards set by authorities such…

Continue Reading Peer Review Checklists for Hold Documentation

Visual Cleanliness Trending vs Analytical Results

Visual Cleanliness Trending vs Analytical Results Visual Cleanliness Trending vs Analytical Results Introduction to Hold-Time Studies in Pharma In the pharmaceutical industry, maintaining strict compliance with regulatory authorities such as the FDA, EMA, and MHRA is paramount. A critical aspect of this compliance involves hold-time studies, which are essential for ensuring that both the microbial and endotoxin limits are within…

Continue Reading Visual Cleanliness Trending vs Analytical Results

Supplier Trend Integration: Letters, CoAs, and Changes

Supplier Trend Integration: Letters, CoAs, and Changes Supplier Trend Integration: Letters, CoAs, and Changes In the pharmaceutical industry, documentation surrounding supplier trends, Certificates of Analysis (CoAs), and equipment hold times is paramount to ensure compliance with Good Manufacturing Practices (cGMP) as defined by regulatory authorities like the US FDA, EMA, and MHRA. This comprehensive guide aims to provide a step-by-step…

Continue Reading Supplier Trend Integration: Letters, CoAs, and Changes

Template Pack: Protocol, Report, and Log Sheets

Template Pack: Protocol, Report, and Log Sheets Template Pack: Protocol, Report, and Log Sheets In the pharmaceutical industry, maintaining compliance with regulatory expectations surrounding hold time studies is essential for ensuring product quality and patient safety. This guide outlines a systematic approach to developing documentation for hold-time studies pertaining to bulk materials, intermediate products, and cleaning processes. Following these protocols…

Continue Reading Template Pack: Protocol, Report, and Log Sheets

When to Retire Hold Claims: Trending Evidence

When to Retire Hold Claims: Trending Evidence When to Retire Hold Claims: Trending Evidence Introduction to Hold Claims in Pharmaceutical Manufacturing In pharmaceutical manufacturing, the understanding and management of hold times for different processes, namely bulk hold time and intermediate hold time, represent crucial steps in ensuring product quality and compliance with regulatory guidelines such as FDA and EMA. Hold…

Continue Reading When to Retire Hold Claims: Trending Evidence